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Oil Red O Staining
Conclusions
References
If MMP inhibition prevents activation of the transcription factor
CCAAT/enhancer-binding protein β (C/EBPβ), the effect of Ilomostat
should overcome the upregulation of downstream PPARγ by
rosiglitazone.
Maintenance of 3T3-L1 Cell Line. 3T3-L1 cells (American Type Culture Collection) were
maintained in T-25 Flasks in 10% calf serum/DMEM media (Dulbecco’s Modified Eagle Media
with 10% donor bovine serum, 1% penicillin/streptomycin, 1% sodium pyruvate, and 1% L-
glutamine). Cells were incubated at 37oC with 10% CO2. Media was changed every two days
until 70% confluency, when cells were split.
Differentiation Protocol. Cells were plated in 6-well plates in fresh media until 100%
confluency. Two days post confluency (Day 0), the differentiation media was added, 10%
FBS/DMEM media with 1:1000 isobutylmethylxanthine, 1:1000 dexamethasone, and 1:1000
insulin. On Day 2 the media was replaced with 10% FBS/DMEM media with 1:1000 insulin.
On Day 4, the media was replaced with only 10% FBS/DMEM media. Every two days
thereafter the media was changed to fresh differentiation media, until Day 8.
Treatment Protocol. Cells were treated with rosiglitazone at 2 µM, added on Day 0 of
treatment and incubated with the cells for two days. Ilomostat was added at a concentration
of 25 µM, added at Day 0 and every 2 days through differentiation. Differentiation and
growth media controls received 40 µL of DMSO.
Oil Red O Staining. Oil Red O Staining was used to measure lipid accumulation on Day 8..
Pictures of the cells with the stain were taken to observe lipid accumulation. Once the stain
was extracted, the absorbances of diluted solutions were measured at 520 nm.
Western Blotting: Protein Extraction. At desired time points in the differentiation, media
was removed and the cells were washed with 1x PBS, and then suspended in 100 µL of
Laemmli buffer. The samples were frozen and stored at -20 oC.
Gel Electrophoresis and Protein Transfer. Frozen protein samples were prepared by heating
for three minutes at 95 oC. Proteins were separated by SDS-page using a 10% SDS gel
(BioRad). Proteins were transferred and immobilized on a nitrocellulose membrane at 4 oC.
Blotting. The membranes were blocked in 5% non-fat milk in TBST at room temperature for
one hour. Membranes were incubated at 4oC in an anti-PPARγ purified rabbit monoclonal
antibody (abcam) 1:1000. Membranes were incubated in secondary antibody for one hour at
room temperature in donkey anti-rabbit HRP antibody (abcam) 1:5000. Membranes were
imaged using an ImageQuant LAS 4000.
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Figure 2: Extracellular matrix remodeling is a critical adipogenesis process .
Preadipocyte ECM is supported by type 1 and type IV collagen fibers and a
fibronectin network. MMPs in cell membrane cleave integrin attachments to
fibronectin during adipogenesis facilitating the switch to a laminin network in
mature adipocytes.
Model
Figure 5: Oil Red O staining on Day 8 of treatment. Samples (n=6) were
measured at 520 nm to measure lipid accumulation in cells, with higher lipid
accumulation indicating more cells that underwent adipogenesis. Values were
normalized to the differentiation media control for comparison of trials. Cells
treated with only rosiglitazone showed the highest level of lipid. Cells treated
with Ilomostat showed lipid levels lower than both rosiglitazone and the
differentiation control. Indicating Ilomostat overcame the upregulation of
PPARγ by rosiglitazone on the cells.
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Figure 4: Cell imaging of treatment cells on Day 8. (A) After Oil Red O staining,
the red color indicates lipid accumulation in cells. (B) Cells imaged with a light
microscope show lipid droplets in cells that underwent adipogenesis. In both A
and B cells treated with just rosiglitazone have increased lipid than the control.
Cells treated with rosiglitazone and Ilomostat have decreased lipid than both
controls and rosiglitazone alone. This indicates Ilomostat can overcome the
effect of rosiglitazone, suggesting that inhibiting MMPs can overcome PPARγ
upregulation.
Hypothesis


















(Liu et al., 2012)
No Ilomostat Ilomostat
• The effect of Ilomostat cannot be rescued by treatment with 
rosiglitazone
• MMP inhibition prevents adipogenesis despite the addition of a 
PPARγ agonist
• Rosiglitazone functions if PPARγ protein is present, therefore the 
decrease in PPARγ expression may be from decreasing PPARγ
transcription
• This study supports the proposal that MMP inhibition decreases 
the ability of C/EBPβ to bind DNA and induce PPARγ transcription
Future Directions 
• Measure C/EBPβ expression after treatments with 
rosiglitazone and Ilomostat
• Inhibit specific MMPs in the membrane and study their 
effect on adipogenic signaling
• Clarification of the downstream effects of MMP signaling during 
adipogenesis will provide more insight into specific targets for 
obesity treatment 
Figure 6: Western Blot to confirm PPARγ expression. anti-PPARγ purified
rabbit monoclonal antibody was used to blot for PPARγ shown at 58 kD. PPARγ
expression appears slightly upregulated in rosiglitazone treatments. Cells with
rosiglitazone and Ilomostat show slightly less PPARγ expression than
rosiglitazone.
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Figure 3: Model of Ilomostat/rosiglitazone signaling interaction. MMP
inhibition with Ilomostat may be correlated with a decrease in CEBPβ DNA
binding capacity (Croissandeau et al., 2002), which leads to reduced
transcriptional activation of PPARγ, and would decrease the effect of
rosiglitazone. Details on the signaling events between MMP function and
intracellular signals is not well understood.
The growing obesity epidemic has led to an increased interest in the study of adipogenesis, or
fat cell development. Obesity has been shown to increase the risk of type II diabetes, high
blood pressure, and a number of other diseases. 3T3-L1 fibroblast cells are a key model
system to study the signaling events in the differentiation of preadipocytes into mature
adipocytes. Extracellular matrix remodeling is a critical process during adipogenesis and is
facilitated by matrix metalloproteinases (MMPs). Despite the known importance of
extracellular matrix signaling, much of these signaling pathways are not well understood in
adipogenesis. MMP inhibition has been shown to inhibit adipogenesis and be correlated with
a decrease in the peroxisome-proliferator-activated receptor γ (PPARγ). To better understand
the importance of MMPs in adipogenesis, the MMP inhibitor Ilomostat was used on mouse
3T3-L1 preadipocytes in addition to the PPARγ agonist rosiglitazone. We predicted that if
MMP inhibition prevents activation of the transcription factor CCAAT/enhancer-binding
protein β (C/EBPβ), the effect of Ilomostat should overcome the upregulation of downstream
PPARγ by rosiglitazone. Results suggest that treatment with the inhibitor prevents adipogenic
conversion despite the addition of the PPARγ agonist. Western Blot analysis showed that
PPARγ expression was slightly upregulated in cells treated with rosiglitazone, and decreased
in cells treated with both drugs. The results of this study will help clarify the downstream
effects of MMP signaling during adipogenesis and provide insight into specific targets for
obesity treatment.
Figure 1: Intracellular signaling events in adipogenesis. Control of
adipogenesis is dependent on regulation of PPARγ and CEBP family
transcription factors. PPARγ is the master regulator of adipogenesis, but it is
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